000 | 01988 a2200493 4500 | ||
---|---|---|---|
005 | 20250517205044.0 | ||
264 | 0 | _c20180619 | |
008 | 201806s 0 0 eng d | ||
022 | _a1421-9778 | ||
024 | 7 |
_a10.1159/000488183 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXia, Pingping | |
245 | 0 | 0 |
_aPioglitazone Confers Neuroprotection Against Ischemia-Induced Pyroptosis due to its Inhibitory Effects on HMGB-1/RAGE and Rac1/ROS Pathway by Activating PPAR-ɤ. _h[electronic resource] |
260 |
_bCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology _c2018 |
||
300 |
_a2351-2368 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAstrocytes _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aGlucose _ximmunology |
650 | 0 | 4 |
_aHMGB1 Protein _ximmunology |
650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeuroprotection _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
650 | 0 | 4 |
_aPPAR gamma _ximmunology |
650 | 0 | 4 | _aPioglitazone |
650 | 0 | 4 |
_aPyroptosis _xdrug effects |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReactive Oxygen Species _ximmunology |
650 | 0 | 4 |
_aReceptor for Advanced Glycation End Products _ximmunology |
650 | 0 | 4 |
_aReperfusion Injury _xdrug therapy |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aThiazolidinediones _xtherapeutic use |
650 | 0 | 4 |
_arac1 GTP-Binding Protein _ximmunology |
700 | 1 | _aPan, Yundan | |
700 | 1 | _aZhang, Fan | |
700 | 1 | _aWang, Na | |
700 | 1 | _aWang, E | |
700 | 1 | _aGuo, Qulian | |
700 | 1 | _aYe, Zhi | |
773 | 0 |
_tCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology _gvol. 45 _gno. 6 _gp. 2351-2368 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000488183 _zAvailable from publisher's website |
999 |
_c28194054 _d28194054 |